As the artificial intelligence boom accelerates, experts warn of a potential speculative bubble reminiscent of the late 90s dot-com crash. Companies are investing billions in AI technology, but will it end in disaster?
In a controversial move, Apple and Google have removed apps that alert users about nearby ICE agents after pressure from Attorney General Pam Bondi. Critics argue this capitulation underscores the Trump administration's influence over Silicon Valley.
President Trump is contemplating significant tariff relief for U.S. automakers, potentially slashing costs for major companies like Ford and GM. This move could incentivize domestic production and create jobs, following his key policy goals.
Pfizer's unexpected deal with the Trump administration on drug pricing sends shockwaves through the pharmaceutical industry, pressuring competitors to follow suit amidst potential regulatory threats. What’s next for drug prices?
President Trump is set to unveil a new strategy to lower drug costs, including the launch of a 'TrumpRx' website for discounted medications and a deal with Pfizer. This move aims to tackle high prescription prices that burden American patients.
In a landmark settlement, YouTube agrees to pay $24.5 million to Donald Trump after suspending his account post-Jan. 6 Capitol attacks. The deal includes funds for the National Mall and a White House ballroom.
YouTube has reached a $24.5 million settlement with Trump following his suspension from the platform after the January 6 insurrection. This marks the final resolution among the major tech companies involved in Trump's lawsuits.
As AI firms attract massive investments reminiscent of the dot-com era, experts question whether current valuations can be sustained. Explore the parallels and pitfalls of today’s AI boom compared to the late 90s tech economy.
Singapore's pharmaceutical companies are anxious about new U.S. tariffs on branded drugs. Deputy PM Gan Kim Yong seeks clarity on tariff exemptions as firms plan U.S. expansions. Can they remain competitive?
In a surprising announcement, President Trump declared a 100% tariff on patented pharmaceuticals unless companies manufacture in the U.S., leaving many confused about the implications for drug prices and healthcare.
